Comparison of DWI and 18F-FDG PET/CT for assessing preoperative N-staging in gastric cancer: evidence from a meta-analysis
- PMID: 29137440
- PMCID: PMC5663612
- DOI: 10.18632/oncotarget.21055
Comparison of DWI and 18F-FDG PET/CT for assessing preoperative N-staging in gastric cancer: evidence from a meta-analysis
Abstract
The diagnostic values of diffusion weighted imaging (DWI) and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for N-staging of gastric cancer (GC) were identified and compared. After a systematic search to identify relevant articles, meta-analysis was used to summarize the sensitivities, specificities, and areas under curves (AUCs) for DWI and PET/CT. To better understand the diagnostic utility of DWI and PET/CT for N-staging, the performance of multi-detector computed tomography (MDCT) was used as a reference. Fifteen studies were analyzed. The pooled sensitivity, specificity, and AUC with 95% confidence intervals of DWI were 0.79 (0.73-0.85), 0.69 (0.61-0.77), and 0.81 (0.77-0.84), respectively. For PET/CT, the corresponding values were 0.52 (0.39-0.64), 0.88 (0.61-0.97), and 0.66 (0.62-0.70), respectively. Comparison of the two techniques revealed DWI had higher sensitivity and AUC, but no difference in specificity. DWI exhibited higher sensitivity but lower specificity than MDCT, and 18F-FDG PET/CT had lower sensitivity and equivalent specificity. Overall, DWI performed better than 18F-FDG PET/CT for preoperative N-staging in GC. When the efficacy of MDCT was taken as a reference, DWI represented a complementary imaging technique, while 18F-FDG PET/CT had limited utility for preoperative N-staging.
Keywords: diffusion weighted imaging; gastric cancer; lymph node staging; positron emission tomography/computed tomography.
Conflict of interest statement
CONFLICTS OF INTEREST None.
Figures






Similar articles
-
18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.Invest Radiol. 2016 Mar;51(3):163-9. doi: 10.1097/RLI.0000000000000218. Invest Radiol. 2016. PMID: 26784400 Free PMC article.
-
Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?J Surg Res. 2012 Nov;178(1):304-14. doi: 10.1016/j.jss.2012.03.074. Epub 2012 Apr 22. J Surg Res. 2012. PMID: 22541065
-
Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.Scand J Urol Nephrol. 2011 Mar;45(2):122-8. doi: 10.3109/00365599.2010.544672. Epub 2011 Jan 13. Scand J Urol Nephrol. 2011. PMID: 21231796
-
Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.Acad Radiol. 2012 Mar;19(3):349-57. doi: 10.1016/j.acra.2011.10.018. Epub 2011 Dec 14. Acad Radiol. 2012. PMID: 22173321 Review.
-
Impact of 18F-FDG PET/CT in Staging Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.Front Med (Lausanne). 2020 Jan 29;6:336. doi: 10.3389/fmed.2019.00336. eCollection 2019. Front Med (Lausanne). 2020. PMID: 32118000 Free PMC article.
Cited by
-
Gastric cancer and imaging biomarkers: Part 1 - a critical review of DW-MRI and CE-MDCT findings.Eur Radiol. 2019 Apr;29(4):1743-1753. doi: 10.1007/s00330-018-5732-4. Epub 2018 Oct 2. Eur Radiol. 2019. PMID: 30280246 Free PMC article. Review.
-
Chinese national clinical practice guidelines on the prevention, diagnosis, and treatment of early gastric cancer.Chin Med J (Engl). 2024 Apr 20;137(8):887-908. doi: 10.1097/CM9.0000000000003101. Epub 2024 Mar 21. Chin Med J (Engl). 2024. PMID: 38515297 Free PMC article.
-
Diffusion-Weighted Imaging in Oncology: An Update.Cancers (Basel). 2020 Jun 8;12(6):1493. doi: 10.3390/cancers12061493. Cancers (Basel). 2020. PMID: 32521645 Free PMC article. Review.
-
A Meta-Analysis And Systematic Review Of Accuracy Of Endoscopic Ultrasound For N Staging Of Gastric Cancers.Cancer Manag Res. 2019 Sep 27;11:8755-8764. doi: 10.2147/CMAR.S200318. eCollection 2019. Cancer Manag Res. 2019. PMID: 31632135 Free PMC article.
-
Is Accurate N - Staging for Gastric Cancer Possible?Front Surg. 2018 May 31;5:41. doi: 10.3389/fsurg.2018.00041. eCollection 2018. Front Surg. 2018. PMID: 29904636 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30. https://doi.org/10.3322/caac.21387. - DOI - PubMed
-
- de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am. 2013;42:219–240. https://doi.org/10.1016/j.gtc.2013.01.003. - DOI - PubMed
-
- Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver 4) Gastric Cancer. 2017;20:1–19. https://doi.org/10.1007/s10120-016-0622-4. - DOI - PMC - PubMed
-
- Ono H, Yao K, Fujishiro M, Oda I, Nimura S, Yahagi N, Iishi H, Oka M, Ajioka Y, Ichinose M, Matsui T. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc. 2016;28:3–15. https://doi.org/10.1111/den.12518. - DOI - PubMed
-
- Eom BW, Yu JS, Ryu KW, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Choi IJ, Yoon HM, Kim YW. Optimal submucosal invasion of early gastric cancer for endoscopic resection. Ann Surg Oncol. 2015;22:1806–1812. https://doi.org/10.1245/s10434-014-4308-z. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous